4 Strategies Behind High-Performing Lung Programs

Pulmonary nodule management extends far beyond the initial imaging finding.

As health systems expand lung cancer screening efforts and formalize incidental pulmonary nodule pathways, increasing attention is being placed on what happens after a nodule is identified. A pulmonary nodule may enter the system through a screening program, an emergency department encounter, a cardiac CT, or routine outpatient imaging. Patients may require serial imaging over months or years, multidisciplinary review, referral to pulmonary specialists, diagnostic workup, or ongoing surveillance based on evolving risk assessments. Throughout that process, continuity of care becomes just as important as the original finding itself.

For pulmonologists and lung program leaders, the challenge is rarely determining the appropriate next step. Established guidelines provide a framework for surveillance and follow-up. The greater challenge is maintaining continuity across a pathway that may span multiple departments, multiple care teams, and multiple surveillance intervals over time. The question now is: how do programs maintain visibility and continuity from the moment a pulmonary nodule is identified through specialist evaluation and intervention when necessary?

This is one of the reasons high-performing lung programs increasingly focus on continuity as a core operational objective. The goal is not simply to identify pulmonary nodules. The goal is to ensure that appropriate patients continue moving through surveillance, specialist evaluation, and intervention pathways in a timely and coordinated manner.

In this guide, we'll look at four operational strategies high-performing lung screening programs and incidental nodule clinics use to improve pulmonary nodule follow-up and create more reliable continuity across lung cancer care.

One of the biggest reasons patients drift after pulmonary nodules are identified is unclear follow-up ownership. Maintaining continuity across pulmonary nodule surveillance often requires coordination between radiology, pulmonology, primary care, navigation teams, and scheduling staff. When ownership of the next step is not clearly defined, surveillance recommendations can become difficult to operationalize consistently across the pathway.

In many lung screening programs and incidental nodule clinics, surveillance responsibility becomes distributed across radiology, pulmonology, primary care, navigation teams, and schedulers. Recommendations may exist inside reports, referrals may technically be placed correctly, and surveillance intervals may already be documented, yet patients still fall through gaps because continuity depends heavily on manual coordination.

This becomes especially important for incidental pulmonary nodules discovered during imaging performed for unrelated reasons. Once the patient leaves the radiology workflow, maintaining visibility into the next step often becomes difficult.

Programs that scale successfully reduce this ambiguity early. They create structured workflows that help pulmonologists and program leads maintain visibility into unresolved findings, overdue surveillance, delayed referrals, and patients who still require action.

Several operational patterns consistently appear across stronger programs:

These programs spend less time trying to determine who owns the next step and more time keeping patients moving through surveillance consistently.

Pulmonary nodule management rarely happens during a single encounter.

Pulmonologists often make decisions based on how findings evolve over time, including prior imaging, interval growth, surveillance adherence, referral history, and changing risk profiles. Lung program leads face a similar operational challenge. Understanding where patients are within the pathway becomes increasingly difficult as surveillance volumes rise.

Many lung programs still manage this information across PACS, EMRs, spreadsheets, navigation notes, referral systems, and manual reminders. By the time patients reach specialist evaluation, continuity may already be incomplete.

High-performing lung screening programs and incidental nodule clinics approach this differently. They create a clearer operational view across imaging, referrals, surveillance timelines, and follow-up history so teams can understand how the patient has moved through the pathway over time.

Programs using longitudinal patient management systems such as qTrack help pulmonologists and lung program leads maintain continuity across surveillance workflows without increasing administrative burden. Instead of reconstructing fragmented histories manually, teams can quickly identify where patients are within the program and what action still needs to happen.

This becomes especially valuable for patients with delayed referrals, overdue surveillance imaging, interval growth across scans, or findings discovered outside formal screening programs where continuity can weaken quickly once the patient leaves the initial imaging workflow.

The strongest lung programs understand that pulmonary nodule care extends far beyond the initial diagnostic event. Patients often move through surveillance intervals, referrals, repeat imaging, and intervention planning over months or years. Maintaining continuity across that journey becomes increasingly important as screening programs and incidental detection volumes continue to scale.

Many lung cancer pathways lose momentum during the transition between detection and specialist evaluation. 

A pulmonary nodule may be identified during routine imaging, a recommendation may appear clearly inside the report, and a referral may technically exist within the Electronic Medical Record (EMR), yet delays still emerge because the pathway between detection and action contains too many disconnected steps. Pulmonologists and lung program leads experience the downstream impact of this directly. Surveillance intervals stretch longer than intended, referrals slow down, and patients sometimes reach specialist evaluation later than expected.

High-performing programs reduce these delays by simplifying how patients move from detection to pulmonology evaluation and intervention planning. They create clearer referral pathways, reduce dependency on manual handoffs, and improve coordination between radiology, pulmonology, and navigation teams so patients move through the pathway with less friction.

Several programs are also expanding earlier detection opportunities during routine chest imaging. Chest X-ray AI tools such as qXR-LN help radiologists identify subtle pulmonary nodules during high-volume reads without disrupting existing workflows, helping more patients enter the pathway earlier.

The strongest programs understand that detection quality shapes the beginning of the pathway, while continuity afterward determines whether patients receive timely specialist evaluation.

As pulmonary nodule volumes continue to rise, maintaining consistency across surveillance decisions becomes increasingly difficult.

Thoracic radiologists and pulmonologists work in environments defined by subtle findings, high imaging volumes, competing priorities, and multiple guideline considerations. Small

differences in interpretation, measurement, or follow-up recommendations can create significant downstream variation across the pathway.

High-performing lung programs reduce this variability by creating more standardized approaches to pulmonary nodule surveillance while preserving clinical judgment within existing workflows.

Quantification tools such as qCT-LN Quant help support reproducible volumetric measurements and longitudinal growth tracking across chest CT workflows, helping pulmonologists and radiologists make more consistent follow-up decisions across different readers and time points.

The strongest surveillance programs typically create:

The goal is maintaining consistency across high-volume workflows where subtle findings can otherwise receive very different surveillance recommendations over time.

The most effective lung screening programs and incidental nodule clinics reduce fragmentation across the entire continuum of care and create stronger continuity between detection, surveillance, referral management, and specialist evaluation.

Pulmonologists and lung program leads experience different parts of the same operational challenge every day. Follow-up timelines stretch, referrals slow down, visibility across the patient journey weakens, and continuity becomes harder to maintain as imaging volumes increase.

Pulmonary nodule management is inherently longitudinal. Detection, surveillance, specialist evaluation, and intervention planning occur across multiple encounters and often across multiple departments. Programs that maintain visibility across each stage of that pathway are generally better positioned to support timely evaluation and coordinated care.

As lung cancer programs continue to scale, the challenge is no longer simply identifying more pulmonary nodules. The larger challenge is ensuring fewer patients disappear between detection and decision-making.

Stop Losing Patients Between Detection and Follow-Up.

See how you can make the most out of your lung program.